For the purposes of placing a custom-made medical device on the market, the manufacturer shall follow the procedure defined in Article R. 5211-51.
The Director General of the Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products) may require the manufacturer of such devices to provide it with a list of the devices it has produced and which have been put into service on French territory, as well as the declarations and documentation relating to these devices.